Analyte measured to Lymecycline bioequivalence study [Bioanalytics]

posted by Mauricio Sampaio  – Brazil, 2013-09-02 17:50 (4668 d 03:55 ago) – Posting: # 11409
Views: 10,596

Dear,

in Public Assessment Report of Lymecycline 408 capsules from MHRA (UK/H/1889/002/DC)* the pharmacokinetics results of bioequivalence study of Lymecycline is based on data from Tetracycline and not Lymecycline (page 13). However, in page 10, the Lymecycline is described as active substance.

In this case Lymecycline is a prodrug and serves as a type of precursor to the intended drug (Tetracycline)?

Please, clarify my doubt.

* http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con205367.pdf

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
110 visitors (0 registered, 110 guests [including 15 identified bots]).
Forum time: 21:46 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5